Viewray Inc Revenue per Employee (VRAY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Viewray Inc   (NASDAQ: VRAY)
 

Viewray Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 19.38% in the first quarter 2023, year on year to cumulative value of $106 million, Viewray Inc 's revenue per employee grew on a trailing twelve months basis to $ 494,692. The productivity of Viewray Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 168 other companies have achieved higher revenue per employee. While Viewray Inc 's total ranking has deteriorated compared to the previous quarter from 1498 to 1506. Viewray Inc has 214 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRAY Revenue per Employee (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Revenue Change 19.38 % 70.16 % 38.13 % 47.37 % 21.58 %
Sales per Employee (TTM) $ 494,692 477,598 410,757 376,584 343,318
VRAY's Total Ranking # 1506 # 1498 # # #
Seq. Revenue Change -35.04 % 30.96 % 19.6 % 17.34 % -7.41 %

VRAY Company Profile >> Back to VRAY Efficiency Comparisons >> Compare VRAY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 29
Healthcare Sector # 169
Overall Market # 1506

Revenue per Employee Statistics
High Average Low
$ 568,215 $ 291,238 $ 3,720
(Dec 31 2022)   (Sep 30 2016)



Financial Statements
Viewray Inc 's Revenue MRQ $ 23 Millions Visit VRAY's Income Statement
Viewray Inc 's Revenues TTM $ 106 Millions Visit VRAY's aggregate revenue growth
What are VRAY's Sales? Visit VRAY's Sales by Segment




Other Ratios
Viewray Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VRAY's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VRAY's Competitors
Revenue per Employee for VRAY's Suppliers
Revenue per Employee for VRAY's Customers

You may also want to know
VRAY's Sales Growth Rates VRAY's Pe Price to earnings ratio VRAY's Receivables Turnover Ratio VRAY's Stock Quote
VRAY's Net Income Growth Rates VRAY's Ps Price to Sales ratio VRAY's Sales per Employee VRAY's Asset Turnover Ratio
VRAY's Net Margin VRAY's Pb Price to Book ratio VRAY's Financial Strength Ratios VRAY's Dividend Payout Ratio
Date modified: 2026-09-12T06:10:03+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2023Number of Employees Mar 31 2023
Lantheus Holdings Inc   860,825.65 $ 1,026.965  Million 1,193 
Patterson Companies Inc   851,509.34 $ 6,471.471  Million 7,600 
Fate Therapeutics Inc   850,099.38 $ 136.866  Million 161 
Fortress Biotech Inc   823,679.49 $ 64.247  Million 78 
Prothena Corporation Public Limited Company  819,716.42 $ 54.921  Million 67 
Whitehawk Therapeutics Inc   816,347.83 $ 18.776  Million 23 
Iteos Therapeutics Inc   813,394.90 $ 127.703  Million 157 
Pacira Biosciences inc   807,205.07 $ 669.173  Million 829 
Ginkgo Bioworks Holdings Inc   804,129.90 $ 390.003  Million 485 
Regeneron Pharmaceuticals Inc   802,719.01 $ 12,369.900  Million 15,410 
Biofrontera Inc   801,630.43 $ 73.750  Million 92 
Neurocrine Biosciences Inc   799,250.00 $ 1,598.500  Million 2,000 
Intercept Pharmaceuticals inc   785,392.00 $ 294.522  Million 375 
Ptc Therapeutics inc   777,445.01 $ 770.448  Million 991 
Merck and Co Inc   771,586.67 $ 57,869.000  Million 75,000 
Repare Therapeutics Inc   768,201.12 $ 137.508  Million 179 
Y mabs Therapeutics inc   750,320.00 $ 75.032  Million 100 
Omniab Inc   745,764.04 $ 66.373  Million 89 
Rigel Pharmaceuticals Inc  744,695.40 $ 129.577  Million 174 
Endo International Plc  744,415.90 $ 2,181.883  Million 2,931 
Cytomx Therapeutics Inc   702,115.94 $ 48.446  Million 69 
Luna Innovations Inc  700,381.25 $ 112.061  Million 160 
Johnson and Johnson  683,686.08 $ 96,263.000  Million 140,800 
Agile Therapeutics Inc  680,842.11 $ 12.936  Million 19 
Enanta Pharmaceuticals Inc  676,466.67 $ 81.176  Million 120 
Biomarin Pharmaceutical Inc  674,664.70 $ 2,173.095  Million 3,221 
Phenomex Inc   674,605.26 $ 76.905  Million 114 
Novan Inc   673,513.51 $ 24.920  Million 37 
Caremax Inc   667,195.00 $ 667.195  Million 1,000 
Biocryst Pharmaceuticals Inc   665,935.63 $ 289.682  Million 435 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.